Malignant Uterine Neoplasm clinical trials
34 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- A Study of VET3-TGI in Patients With Solid Tumors
- Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
- A Study of JNJ-87890387 for Advanced Solid Tumors
- Image-Guided Gynecologic Brachytherapy
- A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- [18F]FES PET/.CT in Uterine Cancer
- Investigations of Reproductive Cancers in Women
- Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Sample Collection for Ongoing Research and Product Evaluation Study
- NYSCF Scientific Discovery Biobank
- A Multi Center Study of Sexual Toxicities After Radiotherapy
- Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
- Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery
- Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
- A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
- Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
- Vaginal Dilator Therapy After Pelvic Radiation
- Addressing Genomic Disparities in Cancer Survivors
- Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
- Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
- Insights Into Participating in Studies for Uterine Cancer
- COQ10 and Vitamin E for Off-Target Radiation Toxicity
- Feasibility of Addressing Sexual Dysfunction in Women with Breast and Gynecologic Cancers with a Novel Mobile Application
- Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
- Study of NEO-201 in Solid Tumors Expansion Cohorts
- Study of INCB123667 in Subjects With Advanced Solid Tumors
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Malignant Uterine Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.